These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34365664)

  • 1. Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing.
    Branch DR; Sandhu G; Raos M
    Transfusion; 2021 Aug; 61(8):2516-2517. PubMed ID: 34365664
    [No Abstract]   [Full Text] [Related]  

  • 2. The Monocyte Monolayer Assay: Past, Present and Future.
    Tong TN; Cen S; Branch DR
    Transfus Med Rev; 2019 Jan; 33(1):24-28. PubMed ID: 30139679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic transfusion reactions in a dog with an alloantibody to a common antigen.
    Callan MB; Jones LT; Giger U
    J Vet Intern Med; 1995; 9(4):277-9. PubMed ID: 8523326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
    Arndt PA; Garratty G
    Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially clinically significant anti-Di
    Branch DR; Holton MB; Ison T; Cote J; Dube C; Lau W
    Transfusion; 2021 Jan; 61(1):331-332. PubMed ID: 33616959
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-coated erythrocytes induce secretion of tumor necrosis factor by human monocytes: a mechanism for the production of fever by incompatible transfusions.
    Hoffman M
    Vox Sang; 1991; 60(3):184-7. PubMed ID: 1862642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interdonor incompatibility due to anti-Kell antibody undetectable by automated antibody screening.
    West NC; Jenkins JA; Johnston BR; Modi N
    Vox Sang; 1986; 50(3):174-6. PubMed ID: 3716289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monocyte monolayer assay, an
    Nance SJT
    Immunohematology; 2023 Jun; 39(2):61-69. PubMed ID: 37405851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte monolayer assay in pre-transfusion testing: A magic key in transfusing patients with recurrent bad cross-match due to alloimmunization.
    El-Sayed HAN; Abdollah MRA; Raafat SN; Ragab D
    J Immunol Methods; 2021 May; 492():112968. PubMed ID: 33465386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal conditions for the performance of a monocyte monolayer assay.
    Tong TN; Burke-Murphy E; Sakac D; Pendergrast J; Cserti-Gazdewich C; Laroche V; Branch DR
    Transfusion; 2016 Nov; 56(11):2680-2690. PubMed ID: 27546234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible case of a haemolytic transfusion reaction caused by anti-Le(a) antibody.
    Duncan V; Pham HP; Williams LA
    Blood Transfus; 2015 Jul; 13(3):535-6. PubMed ID: 26057494
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute hemolytic transfusion reaction caused by anti-Yt
    Raos M; Thornton N; Lukic M; Golubic Cepulic B
    Immunohematology; 2021 Mar; 37(1):13-17. PubMed ID: 33962487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-Ge2 in a Ge: -2, -3 patient].
    Durán-Suárez JR; Sánchez C; Herrero E; Hernández Sánchez JM
    Sangre (Barc); 1991 Aug; 36(4):319-21. PubMed ID: 1776112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with red cell autoantibodies: selection of blood for transfusion.
    Sokol RJ; Hewitt S; Booker DJ; Morris BM
    Clin Lab Haematol; 1988; 10(3):257-64. PubMed ID: 3180694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Irregular erythrocytic antibodies as an obstacle to transfusion].
    Uhlig R; Endert G; Lammel G
    Z Arztl Fortbild (Jena); 1984; 78(20):849-52. PubMed ID: 6523909
    [No Abstract]   [Full Text] [Related]  

  • 20. Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells.
    Boligan KF; Sandhu G; Branch DR
    Curr Protoc; 2022 Aug; 2(8):e504. PubMed ID: 35926124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.